Study to Evaluate Real-world Pharmacoeconomics of Panitumumab in Metastatic Colorectal Cancer Patients

NCT02139215 · clinicaltrials.gov ↗
COMPLETED
Status
72
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

PeriPharm

Collaborators